Financial Ratios

HEMANT SURGICAL INDUSTRIES LTD.

NSE : NABSE : 543916ISIN CODE : INE0GYI01028Industry : Medical Equipment/Supplies/AccessoriesHouse : Private
BSE136.60-3.25 (-2.32 %)
PREV CLOSE ( ) 139.85
OPEN PRICE ( ) 139.75
BID PRICE (QTY) 136.60 (800)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 16800
TODAY'S LOW / HIGH ( )136.60 139.95
52 WK LOW / HIGH ( ) 121260
NSE
This Company is not listed in NSE
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)9.96230.7057.2742.9056.59
   CEPS(Rs)11.0716.765.564.615.21
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)30.73657.39426.69400.73379.60
   Tax Rate(%)23.9224.5124.6710.448.12
Margin Ratios
   Core EBITDA Margin(%)9.666.085.144.614.81
   EBIT Margin(%)11.047.485.574.264.73
   Pre Tax Margin(%)9.215.902.541.712.21
   PAT Margin (%)7.014.451.921.532.03
   Cash Profit Margin (%)7.795.182.982.632.99
Performance Ratios
   ROA(%)12.859.492.722.303.69
   ROE(%)41.6442.5613.8411.0015.82
   ROCE(%)44.9432.8914.3411.6415.23
   Asset Turnover(x)1.832.131.421.511.82
   Sales/Fixed Asset(x)6.246.434.606.047.03
   Working Capital/Sales(x)12.43157.5020.7844.61-4225.18
Efficiency Ratios
   Fixed Capital/Sales(x)0.160.160.220.170.14
   Receivable days54.9335.1129.5835.3934.01
   Inventory Days46.2348.7790.5077.6153.47
   Payable days101.7974.60108.19113.7795.11
Valuation Parameters
   PER(x)0.000.000.000.000.00
   PCE(x)0.000.000.000.000.00
   Price/Book(x)0.000.000.000.000.00
   Yield(%)
   EV/Net Sales(x)0.060.060.250.210.22
   EV/Core EBITDA(x)0.490.703.773.973.78
   EV/EBIT(x)0.530.764.494.994.55
   EV/CE(x)0.100.110.350.290.36
   M Cap / Sales0.000.000.000.000.00
Growth Ratio
   Net Sales Growth(%)5.3973.306.530.7910.11
   Core EBITDA Growth(%)51.72114.5431.58-5.0014.82
   EBIT Growth(%)55.41132.9439.08-9.2012.34
   PAT Growth(%)65.82302.8633.47-24.1920.53
   EPS Growth(%)-95.68302.8633.47-24.1920.53
Financial Stability Ratios
   Total Debt/Equity(x)0.300.741.691.761.50
   Current Ratio(x)1.231.021.131.051.00
   Quick Ratio(x)0.840.670.470.450.53
   Interest Cover(x)6.064.731.841.671.88
   Total Debt/Mcap(x)

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.